Data Insights

Immune globulin (human) by Grifols for Tachycardia (Tachyarrhythmias): Likelihood of Approval

Immune globulin (human) is under clinical development by Grifols and currently in Phase II for Tachycardia (Tachyarrhythmias). According to GlobalData,...

Likelihood of Approval and Phase Transition Success Rate Model - Immune Globulin (Human) in Tachycardia (Tachyarrhythmias)

Data Insights

Immune globulin (human) by Octapharma for Neuropathy: Likelihood of Approval

Immune globulin (human) is under clinical development by Octapharma and currently in Phase II for Neuropathy. According to GlobalData, Phase...

Likelihood of Approval and Phase Transition Success Rate Model - Immune Globulin (Human) in Neuropathy

Data Insights

Immune globulin (human) by Octapharma for Unspecified Neurologic Disorders: Likelihood of Approval

Immune globulin (human) is under clinical development by Octapharma and currently in Phase III for Unspecified Neurologic Disorders. According to...

Data Insights

Immune globulin (human) by Grifols for Coronavirus Disease 2019 (COVID-19): Likelihood of Approval

Immune globulin (human) is under clinical development by Grifols and currently in Phase II for Coronavirus Disease 2019 (COVID-19). According...

Data Insights

Immune globulin (human) by CSL for Chronic Lymphocytic Leukemia (CLL): Likelihood of Approval

Immune globulin (human) is under clinical development by CSL and currently in Phase III for Chronic Lymphocytic Leukemia (CLL). According...

Data Insights

Immune globulin (human) by CSL for Post-Acute Sequelae of COVID 2019 (PASC or Long COVID): Likelihood of Approval

Immune globulin (human) is under clinical development by CSL and currently in Phase III for Post-Acute Sequelae of COVID 2019...

Data Insights

Immune globulin (human) by Octapharma for Neuropathy: Likelihood of Approval

Immune globulin (human) is under clinical development by Octapharma and currently in Phase II for Neuropathy. According to GlobalData, Phase...

Data Insights

Immune globulin (human) by CSL for Traumatic Spinal Cord Injury: Likelihood of Approval

Immune globulin (human) is under clinical development by CSL and currently in Phase I for Traumatic Spinal Cord Injury. According...